Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Pidilizumab> ?p ?o }
Showing triples 1 to 46 of
46
with 100 triples per page.
- Pidilizumab abstract "Pidilizumab (formerly CT-011) is a monoclonal antibody being developed by Medivation for the treatment of cancer and infectious diseases. Pidilizumab was originally thought to bind to the PD-1 immune checkpoint molecule, but this is currently uncertain. Pidilizumab causes in the attenuation of apoptotic processes in lymphocytes, primarily effector/memory T cells.".
- Pidilizumab atcPrefix "none".
- Pidilizumab casNumber "1036730-42-3".
- Pidilizumab wikiPageID "36964640".
- Pidilizumab wikiPageLength "2790".
- Pidilizumab wikiPageOutDegree "6".
- Pidilizumab wikiPageRevisionID "707385729".
- Pidilizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Pidilizumab wikiPageWikiLink Diffuse_large_B-cell_lymphoma.
- Pidilizumab wikiPageWikiLink Follicular_lymphoma.
- Pidilizumab wikiPageWikiLink Immune_checkpoint.
- Pidilizumab wikiPageWikiLink Medivation.
- Pidilizumab wikiPageWikiLink Programmed_cell_death_protein_1.
- Pidilizumab wikiPageWikiLinkText "Pidilizumab".
- Pidilizumab atcPrefix "none".
- Pidilizumab c "6424".
- Pidilizumab casNumber "1036730".
- Pidilizumab chemspiderid "none".
- Pidilizumab h "9920".
- Pidilizumab molecularWeight "147.43".
- Pidilizumab n "1704".
- Pidilizumab o "2002".
- Pidilizumab s "48".
- Pidilizumab source "zu/o".
- Pidilizumab target "PD-1".
- Pidilizumab type "mab".
- Pidilizumab wikiPageUsesTemplate Template:Drugbox.
- Pidilizumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Pidilizumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Pidilizumab subject Category:Monoclonal_antibodies.
- Pidilizumab hypernym Antibody.
- Pidilizumab type ChemicalSubstance.
- Pidilizumab type Drug.
- Pidilizumab type Antibody.
- Pidilizumab type Chemical.
- Pidilizumab type Drug.
- Pidilizumab type ChemicalObject.
- Pidilizumab type Thing.
- Pidilizumab type Q8386.
- Pidilizumab comment "Pidilizumab (formerly CT-011) is a monoclonal antibody being developed by Medivation for the treatment of cancer and infectious diseases. Pidilizumab was originally thought to bind to the PD-1 immune checkpoint molecule, but this is currently uncertain. Pidilizumab causes in the attenuation of apoptotic processes in lymphocytes, primarily effector/memory T cells.".
- Pidilizumab label "Pidilizumab".
- Pidilizumab sameAs Q7191298.
- Pidilizumab sameAs m.0n46n7q.
- Pidilizumab sameAs Q7191298.
- Pidilizumab wasDerivedFrom Pidilizumab?oldid=707385729.
- Pidilizumab isPrimaryTopicOf Pidilizumab.